As we enter 2022 and exit what has been two of the most challenging years many of us have lived through, I wanted to take a moment to pause and reflect on what has been a truly remarkable year at MedRhythms.

MedRhythms strives to keep its finger on the pulse of the digital therapeutics (DTx) industry in order to draw actionable insights about an industry that

The unfolding COVID-19 pandemic has profoundly affected our way of life by limiting our ability to move, to work, and to interact with others. We

Over the past few years, digital therapeutics have emerged as a new asset class in healthcare. Recently, the digital therapeutics industry has seen significant growth